カテゴリー： GlobalInfoResearch, 世界

サイトメガロウイルス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Cytomegalovirus Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102890）・商品コード：GIR9102890
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、サイトメガロウイルス治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。サイトメガロウイルス治療の世界市場概観、企業動向、企業別サイトメガロウイルス治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・サイトメガロウイルス治療の市場概観
・サイトメガロウイルス治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・サイトメガロウイルス治療の企業別販売動向、市場シェア、市場集中度、競争動向
・サイトメガロウイルス治療の世界市場規模
・サイトメガロウイルス治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・サイトメガロウイルス治療のアメリカ市場規模推移
・サイトメガロウイルス治療のカナダ市場規模推移
・サイトメガロウイルス治療のメキシコ市場規模推移
・サイトメガロウイルス治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・サイトメガロウイルス治療のドイツ市場規模推移
・サイトメガロウイルス治療のイギリス市場規模推移
・サイトメガロウイルス治療のロシア市場規模推移
・サイトメガロウイルス治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・サイトメガロウイルス治療の日本市場規模推移
・サイトメガロウイルス治療の中国市場規模推移
・サイトメガロウイルス治療の韓国市場規模推移
・サイトメガロウイルス治療のインド市場規模推移
・サイトメガロウイルス治療の東南アジア市場規模推移
・サイトメガロウイルス治療の南米市場分析（ブラジル、アルゼンチン等）
・サイトメガロウイルス治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・サイトメガロウイルス治療の種類別分析/販売量、売上、市場シェア（ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他）
・サイトメガロウイルス治療の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局）
・サイトメガロウイルス治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・サイトメガロウイルス治療の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Cytomegalovirus (CMV) is a genus of viruses in the order Herpesvirales, in the family Herpesviridae, in the subfamily Betaherpesvirinae. Humans and monkeys serve as natural hosts.

Scope of the Report:
The global Cytomegalovirus Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cytomegalovirus Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cytomegalovirus Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cytomegalovirus Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Merck
Roche
Pfizer
GlaxoSmithKline
Shire
Abbott Laboratories
Johnson & Johnson
Mylan
Chimerix

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Ganciclovir
Valganciclovir
Foscarnet
Cidofovir
Others

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

1 Cytomegalovirus Treatment Market Overview
1.1 Product Overview and Scope of Cytomegalovirus Treatment
1.2 Classification of Cytomegalovirus Treatment by Types
1.2.1 Global Cytomegalovirus Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Cytomegalovirus Treatment Revenue Market Share by Types in 2018
1.2.3 Ganciclovir
1.2.4 Valganciclovir
1.2.5 Foscarnet
1.2.6 Cidofovir
1.2.7 Others
1.3 Global Cytomegalovirus Treatment Market by Application
1.3.1 Global Cytomegalovirus Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Cytomegalovirus Treatment Market by Regions
1.4.1 Global Cytomegalovirus Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cytomegalovirus Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cytomegalovirus Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cytomegalovirus Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cytomegalovirus Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cytomegalovirus Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Cytomegalovirus Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Cytomegalovirus Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Cytomegalovirus Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Cytomegalovirus Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Cytomegalovirus Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Shire
2.5.1 Business Overview
2.5.2 Cytomegalovirus Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Shire Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Abbott Laboratories
2.6.1 Business Overview
2.6.2 Cytomegalovirus Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Cytomegalovirus Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mylan
2.8.1 Business Overview
2.8.2 Cytomegalovirus Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Chimerix
2.9.1 Business Overview
2.9.2 Cytomegalovirus Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Chimerix Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cytomegalovirus Treatment Market Competition, by Players
3.1 Global Cytomegalovirus Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cytomegalovirus Treatment Players Market Share
3.2.2 Top 10 Cytomegalovirus Treatment Players Market Share
3.3 Market Competition Trend
4 Global Cytomegalovirus Treatment Market Size by Regions
4.1 Global Cytomegalovirus Treatment Revenue and Market Share by Regions
4.2 North America Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
5 North America Cytomegalovirus Treatment Revenue by Countries
5.1 North America Cytomegalovirus Treatment Revenue by Countries (2014-2019)
5.2 USA Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
6 Europe Cytomegalovirus Treatment Revenue by Countries
6.1 Europe Cytomegalovirus Treatment Revenue by Countries (2014-2019)
6.2 Germany Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
6.4 France Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cytomegalovirus Treatment Revenue by Countries
7.1 Asia-Pacific Cytomegalovirus Treatment Revenue by Countries (2014-2019)
7.2 China Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
7.5 India Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
8 South America Cytomegalovirus Treatment Revenue by Countries
8.1 South America Cytomegalovirus Treatment Revenue by Countries (2014-2019)
8.2 Brazil Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cytomegalovirus Treatment by Countries
9.1 Middle East and Africa Cytomegalovirus Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
10 Global Cytomegalovirus Treatment Market Segment by Type
10.1 Global Cytomegalovirus Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Cytomegalovirus Treatment Market Forecast by Type (2019-2024)
10.3 Ganciclovir Revenue Growth Rate (2014-2024)
10.4 Valganciclovir Revenue Growth Rate (2014-2024)
10.5 Foscarnet Revenue Growth Rate (2014-2024)
10.6 Cidofovir Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Cytomegalovirus Treatment Market Segment by Application
11.1 Global Cytomegalovirus Treatment Revenue Market Share by Application (2014-2019)
11.2 Cytomegalovirus Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Cytomegalovirus Treatment Market Size Forecast (2019-2024)
12.1 Global Cytomegalovirus Treatment Market Size Forecast (2019-2024)
12.2 Global Cytomegalovirus Treatment Market Forecast by Regions (2019-2024)
12.3 North America Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
12.6 South America Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Cytomegalovirus Treatment Picture
Table Product Specifications of Cytomegalovirus Treatment
Table Global Cytomegalovirus Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Cytomegalovirus Treatment Revenue Market Share by Types in 2018
Figure Ganciclovir Picture
Figure Valganciclovir Picture
Figure Foscarnet Picture
Figure Cidofovir Picture
Figure Others Picture
Table Global Cytomegalovirus Treatment Revenue (Million USD) by Application (2014-2024)
Figure Cytomegalovirus Treatment Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Cytomegalovirus Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Cytomegalovirus Treatment Type and Applications
Table Merck Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Cytomegalovirus Treatment Type and Applications
Table Roche Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Cytomegalovirus Treatment Type and Applications
Table Pfizer Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Cytomegalovirus Treatment Type and Applications
Table GlaxoSmithKline Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Cytomegalovirus Treatment Type and Applications
Table Shire Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Cytomegalovirus Treatment Type and Applications
Table Abbott Laboratories Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Cytomegalovirus Treatment Type and Applications
Table Johnson & Johnson Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Cytomegalovirus Treatment Type and Applications
Table Mylan Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Chimerix Basic Information, Manufacturing Base and Competitors
Table Chimerix Cytomegalovirus Treatment Type and Applications
Table Chimerix Cytomegalovirus Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Cytomegalovirus Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Cytomegalovirus Treatment Revenue Share by Players (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Share by Players in 2017
Figure Global Cytomegalovirus Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Cytomegalovirus Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Cytomegalovirus Treatment Revenue Market Share in 2018
Figure Global Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Cytomegalovirus Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Cytomegalovirus Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Market Share by Regions in 2018
Figure North America Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure South America Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table North America Cytomegalovirus Treatment Revenue by Countries (2014-2019)
Table North America Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Cytomegalovirus Treatment Revenue Market Share by Countries in 2018
Figure USA Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table Europe Cytomegalovirus Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Cytomegalovirus Treatment Revenue Market Share by Countries in 2018
Figure Germany Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure UK Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure France Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Cytomegalovirus Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Cytomegalovirus Treatment Revenue Market Share by Countries in 2018
Figure China Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure India Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table South America Cytomegalovirus Treatment Revenue by Countries (2014-2019)
Table South America Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Cytomegalovirus Treatment Revenue Market Share by Countries in 2018
Figure Brazil Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Cytomegalovirus Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cytomegalovirus Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Cytomegalovirus Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Cytomegalovirus Treatment Revenue and Growth Rate (2014-2019)
Table Global Cytomegalovirus Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Cytomegalovirus Treatment Revenue Share by Type (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Share by Type (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Share by Type in 2019
Table Global Cytomegalovirus Treatment Revenue Forecast by Type (2019-2024)
Figure Global Cytomegalovirus Treatment Market Share Forecast by Type (2019-2024)
Figure Global Ganciclovir Revenue Growth Rate (2014-2019)
Figure Global Valganciclovir Revenue Growth Rate (2014-2019)
Figure Global Foscarnet Revenue Growth Rate (2014-2019)
Figure Global Cidofovir Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Cytomegalovirus Treatment Revenue by Application (2014-2019)
Table Global Cytomegalovirus Treatment Revenue Share by Application (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Share by Application (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue Share by Application in 2019
Table Global Cytomegalovirus Treatment Revenue Forecast by Application (2019-2024)
Figure Global Cytomegalovirus Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Cytomegalovirus Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Cytomegalovirus Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Cytomegalovirus Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
Figure Europe Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
Figure South America Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Cytomegalovirus Treatment Revenue Market Forecast (2019-2024)


【掲載企業】

Merck、Roche、Pfizer、GlaxoSmithKline、Shire、Abbott Laboratories、Johnson & Johnson、Mylan、Chimerix、

★調査レポート[サイトメガロウイルス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102890)販売に関する免責事項を必ずご確認ください。
★調査レポート[サイトメガロウイルス治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • サイトメガロウイルス病治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101582 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、サイトメガロウイルス病治療の世界市場について調べ、まとめました。種類別セグメントは、ガンシクロビル、バルガンシクロビル、フォスカルネット、シドフォビル、その他等、用途別セグメントは、幹細胞移植、臓器移植、先天性CMV感染、その他等に区分しました。サイトメガロウイルス病治療の世界市場概観、企業動向、企業別サイトメガロウイルス病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・サイトメガロウイルス病治療の市場概観 ・サイトメガロウイルス病治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・サイトメガロウイルス病治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・サイトメガロウイルス病治療の世界市場規模 ・サイトメガロウイルス病治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・サイトメガロウイルス病治療のアメリカ市場規模推移 ・サイトメガロウイルス病治療のカナダ市場規模推移 ・サイトメガロウイルス病治療のメキシコ市場規模推移 ・サイトメガロウイルス病治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Cytomegalovirus disease (CMV) is a viral infection that can affect one part of the body, such as the eyes, or it can spread throughout the body. Scope of the Report: The global Cytomegalovirus Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important...
  • 自動車表面処理/熱処理の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103059 / GlobalInfoResearch / 2019年9月24日 / 本調査レポートは、自動車表面処理/熱処理の世界市場について調べ、まとめました。種類別セグメントは、化学処理、熱処理、その他等、用途別セグメントは、乗用車、商用車等に区分しました。自動車表面処理/熱処理の世界市場概観、企業動向、企業別自動車表面処理/熱処理シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・自動車表面処理/熱処理の市場概観 ・自動車表面処理/熱処理の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・自動車表面処理/熱処理の企業別販売動向、市場シェア、市場集中度、競争動向 ・自動車表面処理/熱処理の世界市場規模 ・自動車表面処理/熱処理の北米市場分析（アメリカ、カナダ、メキシコ等） ・自動車表面処理/熱処理のアメリカ市場規模推移 ・自動車表面処理/熱処理のカナダ市場規模推移 ・自動車表面処理/熱処理のメキシコ市場規模推移 ・自動車表面処理/熱処理のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Heat treatment and surface modification are the key technologies available today, to enhance the effective use of materials, to achieve the desired properties of the components used in the automotive industries, to save energy and conserve natural resources. Scope of the Report: Heat treatment is a type of surface treatment that includes hardening and thermal diffusion. The global Automotive Surface Treatment/Heat Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in...
  • ジェットラグ治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103709 / GlobalInfoResearch / 2019年9月30日 / 本調査レポートは、ジェットラグ治療の世界市場について調べ、まとめました。種類別セグメントは、処方薬、OTC等、用途別セグメントは、病院薬局、小売薬局、オンライン等に区分しました。ジェットラグ治療の世界市場概観、企業動向、企業別ジェットラグ治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ジェットラグ治療の市場概観 ・ジェットラグ治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ジェットラグ治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・ジェットラグ治療の世界市場規模 ・ジェットラグ治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・ジェットラグ治療のアメリカ市場規模推移 ・ジェットラグ治療のカナダ市場規模推移 ・ジェットラグ治療のメキシコ市場規模推移 ・ジェットラグ治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Description Scope of the Report: The global Jet Lag Treatment market is valued at 384.1 million USD in 2018 and is expected to reach 449.9 million USD by the end of 2024, growing at a CAGR of 4.0% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Jet Lag Treatment. Europe also play important roles in...

    • ◆H&Iグローバルリサーチのお客様（例）◆